Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Agmon-Levin

Showing results (71-80 of 197) with videos related to

Pageof 20
Sort By:
BMC Medicine|April 6, 2013
The thrombophilic network of autoantibodies in celiac diseaseAaron Lerner, Nancy Agmon-Levin, Yinon Shapira, et al.
Clinical and Experimental Rheumatology|October 30, 2020
Rituximab for refractory manifestations of the antiphospholipid syndrome: a multicentre Israeli experienceNancy Agmon-Levin, Mark Berman, Liora Harel, et al.
The Israel Medical Association Journal : IMAJ|September 11, 2025
Navigating Fertility Challenges: A Case Report on Immune Thrombocytopenia and Antiphospholipid Antibodies in a Woman Pursuing PregnancyRoy Bitan, Omri Segal, Mudi Misgav, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 7, 2022
Practice Variations in the Management of Infants With Non-IgE-Mediated Cow's Milk Protein AllergyMaya Granot, Diti Machnes Maayan, Batia Weiss, et al.
Arthritis Care & Research|May 31, 2021
Ethnicity and Antiphospholipid Syndrome in IsraelStanley Niznik, Micha J Rapoport, Orly Avnery, et al.
The Journal of Investigative Dermatology|August 25, 2015
Healthcare Services Utilization and Drug Use in Patients with Chronic UrticariaGuy Shalom, Dennis Linder, Doron Comaneshter, et al.
Harefuah|December 19, 2014
[Allergy to non-steroidal antiinflammatory drugs: recommendations of the Israeli allergy and clinical immunology association]Yuval Tal, Alon Hersheko, Arnon Broides, et al.
Harefuah|December 25, 2013
[Allergy to drugs and contrast media--recommendations of the Israeli Allergy and Clinical Immunology Association]Nancy Agmon-Levin, Yuval Tal, Arnon Broides, et al.
The World Allergy Organization Journal|August 11, 2020
Combination therapy with omalizumab and an immune-suppressive agent for resistant chronic spontaneous rrticaria - A real-life experienceRamit Maoz-Segal, Tanya Levy, Soad Haj-Yahia, et al.
Frontiers in Immunology|January 23, 2026
Terrible APS - a newly defined variant of severe APSStanley Niznik, Tania Zaher, Soad Haj Yehia, et al.
Pageof 20

Showing results (71-80 of 197) with videos related to

Sort By:
Pageof 20
BMC Medicine|April 6, 2013
The thrombophilic network of autoantibodies in celiac diseaseAaron Lerner, Nancy Agmon-Levin, Yinon Shapira, et al.
Clinical and Experimental Rheumatology|October 30, 2020
Rituximab for refractory manifestations of the antiphospholipid syndrome: a multicentre Israeli experienceNancy Agmon-Levin, Mark Berman, Liora Harel, et al.
The Israel Medical Association Journal : IMAJ|September 11, 2025
Navigating Fertility Challenges: A Case Report on Immune Thrombocytopenia and Antiphospholipid Antibodies in a Woman Pursuing PregnancyRoy Bitan, Omri Segal, Mudi Misgav, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 7, 2022
Practice Variations in the Management of Infants With Non-IgE-Mediated Cow's Milk Protein AllergyMaya Granot, Diti Machnes Maayan, Batia Weiss, et al.
Arthritis Care & Research|May 31, 2021
Ethnicity and Antiphospholipid Syndrome in IsraelStanley Niznik, Micha J Rapoport, Orly Avnery, et al.
The Journal of Investigative Dermatology|August 25, 2015
Healthcare Services Utilization and Drug Use in Patients with Chronic UrticariaGuy Shalom, Dennis Linder, Doron Comaneshter, et al.
Harefuah|December 19, 2014
[Allergy to non-steroidal antiinflammatory drugs: recommendations of the Israeli allergy and clinical immunology association]Yuval Tal, Alon Hersheko, Arnon Broides, et al.
Harefuah|December 25, 2013
[Allergy to drugs and contrast media--recommendations of the Israeli Allergy and Clinical Immunology Association]Nancy Agmon-Levin, Yuval Tal, Arnon Broides, et al.
The World Allergy Organization Journal|August 11, 2020
Combination therapy with omalizumab and an immune-suppressive agent for resistant chronic spontaneous rrticaria - A real-life experienceRamit Maoz-Segal, Tanya Levy, Soad Haj-Yahia, et al.
Frontiers in Immunology|January 23, 2026
Terrible APS - a newly defined variant of severe APSStanley Niznik, Tania Zaher, Soad Haj Yehia, et al.
Pageof 20